Related Experiment Video
Updated: Nov 18, 2025

06:52
Reconstruct Human Retinoblastoma In Vitro
Published on: October 11, 2022
1.6K
Recurrent Somatic Chromosomal Abnormalities in Relapsed Extraocular Retinoblastoma
Rosario Aschero1,2, Jasmine H Francis3, Daiana Ganiewich4
1Pathology Service, Hospital de Pediatría JP Garrahan, Buenos Aires 1245, Argentina.
Cancers
|February 11, 2021
Summary
Copy number alterations (CNA) are more prevalent in extraocular retinoblastoma relapse cases than previously reported. Specific CNA, including 11q deletions and BCOR alterations, are linked to aggressive tumors in these patients.
Area of Science:
- Oncology
- Genetics
- Ophthalmology
Background:
- Most retinoblastoma research focuses on intraocular disease.
- Features of extraocular relapse in retinoblastoma remain largely unknown.
Purpose of the Study:
- To describe copy number alterations (CNA) in retinoblastoma patients with extraocular relapse.
- To identify CNA associated with aggressive tumor behavior in this population.
Main Methods:
- Analysis of 23 patients and 27 specimens from 4 centers with extraocular retinoblastoma relapse.
- Utilized SNP array, whole-exome sequencing, IMPACT panel, and CGH array for CNA and BCOR gene alteration analysis.
Main Results:
- All cases exhibited a higher prevalence of CNA compared to intraocular retinoblastoma.
- Common CNA included gains in 1q, 2p, 6p, and loss of 16q.
- Frequent CNA in extraocular relapse: 11q deletions (34.8%), 17q gains (56.5%), 19q loss (30.4%), and BCOR alterations (72.7%).
Conclusions:
- Extraocular retinoblastoma shows a high number of CNA, including 11q deletions, 17q gains, 19q loss, and BCOR alterations.
- These CNA are more common in extraocular relapse and may indicate a more aggressive tumor.
- Identification of these genetic features could inform patient management strategies.
More Related Videos
Related Concept Videos
The Retinoblastoma Gene
4.4K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.4K
Conservative Site-specific Recombination and Phase Variation
6.4K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
6.4K
Rous Sarcoma Virus (RSV) and Cancer
5.8K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.8K
Cancers Originate from Somatic Mutations in a Single Cell
13.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
13.5K

